platinum has been researched along with taxane in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (16.67) | 29.6817 |
| 2010's | 24 (57.14) | 24.3611 |
| 2020's | 11 (26.19) | 2.80 |
| Authors | Studies |
|---|---|
| Albiol, S; Bellmunt, J | 1 |
| Engelholm, SA; Gronlund, B; Horvath, G; Mäenpää, J; Ridderheim, M | 1 |
| Kunitoh, H; Nokihara, H; Ohe, Y; Saijo, N; Sekine, I; Tamura, T; Yamamoto, N | 1 |
| Boxall, J; Collins, DJ; d'Arcy, JA; Lankester, KJ; Leach, MO; Padhani, AR; Rustin, GJ; Stirling, JJ; Taylor, JN; Walker-Samuel, S | 1 |
| Cannon, M; Cmelak, AJ; Forastiere, AA; Gillison, M; Goldwasser, MA; Li, S; Murphy, B; Pinto, H; Rosenthal, DI | 1 |
| Agostini, C; Aleba, A; Cretin, J; Dohollou, N; Ferrero, JM; Fric, D; Geay, JF; Gouttebel, MC; Haddad-Guichard, Z; Hardy-Bessard, AC; Lévy, E; Orfeuvre, H; Paraiso, D; Provencal, J; Pujade-Lauraine, E; Ray-Coquard, I; Salvat, J; Weber, B | 1 |
| Axtell, AE; Drake, RD; Fader, AN; Gehrig, PA; Gibbons, HE; Havrilesky, LJ; Huh, WK; O'Malley, DM; Tuller, E; Zanotti, KM | 1 |
| Del Conte, G; Sessa, C | 1 |
| Boren, TP; Miller, DS | 1 |
| Clamp, AR; Evans, S; Griffiths, RW; Hasan, J; Jayson, GC; Kumaran, GC; Mitchell, CL; Welch, RS; Zee, YK | 1 |
| Aakre, JA; Aubry, MC; Croghan, GA; Cunningham, JM; Johnson, C; Li, Y; Molina, J; Pankratz, VS; Sun, Z; Wampfler, JA; Wang, L; Wu, D; Yang, P | 1 |
| Markman, M | 1 |
| Kamura, T; Kuzuya, K; Noda, K; Ochiai, K; Sugiyama, T; Tamura, K; Ushijima, K | 1 |
| Argiris, A; Ballas, MS; Belani, CP; Davies, A; Edelman, M; Gandara, DR; Gitlitz, BJ; Groshen, S; Hoffman, P; Koczywas, M; Liu, SV; Ramalingam, S; Tsao-Wei, DD; Vokes, EE | 1 |
| Enomoto, T; Kim, A; Naka, T; Ueda, Y | 1 |
| Blank, S; Boyd, L; Czok, S; Eberhardt, S; Lee, SJ; Muggia, F; Muller, CY; Pothuri, B; Rutledge, T; Verschraegen, CF | 1 |
| Bang, YJ; Choi, IS; Han, SW; Im, SA; Kang, EJ; Kim, JH; Kim, JS; Kim, JW; Kim, TY; Kim, YJ; Lee, JS; Lee, KW; Oh, DY | 1 |
| Correa, AM; Erasmus, JJ; Gold, KA; Heymach, J; Kalhor, N; Kim, ES; Lee, JJ; Munden, R; Papadimitrakopoulou, V; Pataer, A; Rice, DC; Swisher, SG; William, WN; Wistuba, II | 1 |
| Aust, S; Cacsire Castillo-Tong, D; Dudek, G; Grimm, C; Horvat, R; Pils, D; Pils, S; Polterauer, S; Reinthaller, A; Schmid, B; Speiser, P | 1 |
| Brown, R; He, Y; Hertz, DL; McLeod, HL; McWhinney-Glass, S; Motsinger-Reif, AA; Paul, J; Winham, SJ; Yen Revollo, J | 1 |
| Allard, A; Bennouna, J; Chadjaa, M; Gorbounova, V; Grossi, F; Kowalski, DM; Reck, M; Rey, A; von Pawel, J | 1 |
| Brachova, P; Button, AM; Carlson, MJ; Dai, D; Devor, EJ; Goodheart, MJ; Leslie, KK; Mott, SL; Mueting, SR; Thiel, KW | 1 |
| Aakre, JA; Johnson, C; Loprinzi, CL; Pankratz, VS; Staff, NP; Velazquez, AI; Windebank, AJ; Yang, P | 1 |
| Ganovska, A; Kovachev, S | 1 |
| Beck, SL; Brown, S; Kolb, NA; Mooney, K; Singleton, JR; Smith, AG; Stoddard, GJ | 1 |
| Chiu, DS; Clarke, BA; Kroeger, DR; Lo, CS; Milne, K; Nelson, BH; Rahimi, K; Sanii, S; Shaw, PA; Talhouk, A | 1 |
| Fujimoto, E; Okame, S; Okazawa-Sakai, M; Shiroyama, Y; Takehara, K; Yokoyama, T | 1 |
| Alaseem, A; Alhazzani, K; Alobid, S; Cheema, K; Dondapati, P; Kaur, P; Levy, A; Rathinavelu, A; Thallapureddy, K | 1 |
| Fujikawa, K; Hatachi, Y; Kato, T; Kotaka, M; Sagawa, T; Satake, H; Tsuji, A; Yasui, H | 1 |
| Bielenberg, DR; Chang, J; Fernandes, D; Gartung, A; Hammock, BD; Huang, S; Hwang, SH; Kieran, MW; Panigrahy, D; Schmidt, BA; Sukhatme, VP; Yang, J; Zurakowski, D | 1 |
| Abrams, G; Chesney, MA; Conley, YP; Cooper, BA; Kober, KM; Levine, JD; Mazor, M; Miaskowski, C; Paul, SM; Schumacher, MA; Topp, K; Wong, ML | 1 |
| Castells, M; Otani, IM | 1 |
| Aytes, A; Bakht, M; Beltran, H; Buisan, O; Bystrup, S; Castro, E; Conteduca, V; Font, A; Indacochea, A; Jimenez, N; Marin-Aguilera, M; Martinez-Balibrea, E; Mellado, B; Olmos, D; Palomero, L; Pardo, JC; Piulats, JM; Ruiz de Porras, V; Solé-Blanch, C; Suarez, JF; Wang, XC | 1 |
| Goldstein, D; Kiernan, MC; Li, T; Mizrahi, D; Park, SB; Timmins, HC | 1 |
| Fujisaki, M; Fujita, S; Futawatari, N; Kikuchi, Y; Mitsumori, N; Murakami, M; Nagaoka, S; Oshima, Y; Otsuka, K; Seto, Y; Shimada, H; Yajima, S; Yamashita, H | 1 |
| Ren, S; Wang, D; Yang, B | 1 |
| Basharina, AA; Bogush, EA; Bogush, TA; Davydov, MM; Kosorukov, VS; Scherbakov, AM | 1 |
| Ayhan, M; Terzioğlu, K | 1 |
| Frountzas, M; Haidopoulos, D; Liatsou, E; Liontos, M; Pergialiotis, V; Rodolakis, A; Sotiropoulou, IM; Thomakos, N | 1 |
| Blyta, A; Hundozi, Z; Hyseni, E; Jashari, F; Kurtishi, I; Myftiu, B; Qorraj Bytyqi, H; Sermaxhaj, F; Shala, N | 1 |
| Cheng, MY; Gao, HF; Ji, F; Li, JQ; Lin, YY; Wang, K; Yang, CQ; Yang, M; Yang, X; Zhang, LL; Zheng, XX; Zhu, T | 1 |
| Li, C; Li, X; Shen, L; Wang, S; Wang, T; Zhai, J | 1 |
7 review(s) available for platinum and taxane
| Article | Year |
|---|---|
New chemotherapy combinations for advanced bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Female; Gemcitabine; Humans; Male; Methotrexate; Neoplasm Metastasis; Platinum; Prognosis; Severity of Illness Index; Survival Analysis; Taxoids; Urinary Bladder Neoplasms; Vinblastine | 2001 |
Therapeutic strategies in epithelial ovarian cancer.
Topics: Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Prognosis; Taxoids | 2012 |
Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors.
Topics: Bridged-Ring Compounds; Drug Resistance, Neoplasm; Female; Focal Adhesion Kinase 1; Humans; Molecular Targeted Therapy; Ovarian Neoplasms; Platinum; Protein Kinase Inhibitors; Taxoids | 2019 |
Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review.
Topics: Antineoplastic Agents; Cancer Survivors; Humans; Life Style; Neurotoxicity Syndromes; Obesity; Peripheral Nervous System Diseases; Platinum; Quality of Life; Risk Factors; Taxoids | 2023 |
Quality of life of ovarian cancer patients treated with combined platinum taxane chemotherapy: a systematic review of the literature.
Topics: Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Female; Humans; Ovarian Neoplasms; Platinum; Quality of Life; Taxoids | 2022 |
Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Neoadjuvant Therapy; Network Meta-Analysis; Platinum; Taxoids; Triple Negative Breast Neoplasms | 2022 |
The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Chemotherapy, Adjuvant; Esophagogastric Junction; Fluorouracil; Humans; Neoadjuvant Therapy; Network Meta-Analysis; Platinum; Stomach Neoplasms; Taxoids | 2022 |
9 trial(s) available for platinum and taxane
| Article | Year |
|---|---|
Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane. Results from a multicenter phase I/II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Drug Administration Schedule; Etoposide; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Taxoids; Topotecan | 2005 |
Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bridged-Ring Compounds; Female; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pelvic Neoplasms; Platinum; Regional Blood Flow; Reproducibility of Results; Taxoids | 2007 |
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Deglutition Disorders; Female; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Pharyngectomy; Platinum; Radiotherapy, Adjuvant; Recovery of Function; Salvage Therapy; Speech Disorders; Taxoids; Treatment Outcome | 2007 |
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum; Taxoids | 2009 |
Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study.
Topics: Adult; Aged; Bridged-Ring Compounds; Camptothecin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Irinotecan; Japan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Platinum; Taxoids | 2013 |
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Ethers, Cyclic; Female; Follow-Up Studies; Furans; Humans; Ketones; Lung Neoplasms; Macrolides; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome | 2012 |
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Taxoids; Treatment Outcome | 2012 |
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Serine; Taxoids; Treatment Outcome | 2014 |
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Drug Administration Schedule; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Platinum; Ramucirumab; Salvage Therapy; Stomach Neoplasms; Survival Analysis; Taxoids | 2018 |
26 other study(ies) available for platinum and taxane
| Article | Year |
|---|---|
Common arm analysis: one approach to develop the basis for global standardization in clinical trials of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Deoxycytidine; Europe; Gemcitabine; Humans; Japan; Lung Neoplasms; Platinum; Retrospective Studies; Survival Rate; Taxoids; United States; Vinblastine; Vinorelbine | 2006 |
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Disease-Free Survival; Female; Humans; Platinum; Recurrence; Retrospective Studies; Taxoids; Uterine Neoplasms | 2009 |
Targeted therapies: tailored treatment for ovarian cancer: are we there yet?
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Taxoids; Treatment Outcome | 2010 |
Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy?
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Papillary; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Taxoids | 2010 |
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Cisplatin; Cytotoxins; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome | 2011 |
Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Deoxycytidine; DNA Repair; ErbB Receptors; Female; Gemcitabine; Glutathione; Glutathione Peroxidase; Humans; Lung Neoplasms; Male; Platinum; Polymorphism, Single Nucleotide; Prognosis; Proto-Oncogene Proteins c-raf; Taxoids | 2011 |
Role of chemotherapy in epithelial ovarian cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Taxoids | 2011 |
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Camptothecin; Carcinoma, Signet Ring Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Retrospective Studies; Salvage Therapy; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2013 |
Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Tomography, X-Ray Computed | 2013 |
Expression of Bcl-2 and the antiapoptotic BAG family proteins in ovarian cancer.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Antineoplastic Agents; Apoptosis Regulatory Proteins; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Taxoids; Transcription Factors | 2013 |
Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Case-Control Studies; Female; Genetic Association Studies; Genotype; Humans; Nervous System Diseases; Odds Ratio; Ovarian Neoplasms; Platinum; Polymorphism, Single Nucleotide; Taxoids | 2013 |
TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.
Topics: Adult; Aged; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Taxoids; Tumor Suppressor Protein p53 | 2015 |
Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cohort Studies; DNA Modification Methylases; DNA Repair Enzymes; Female; Glutathione Peroxidase; Humans; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Peripheral Nervous System Diseases; Peroxidases; Platinum; Polymorphism, Single Nucleotide; Risk Factors; Taxoids; Tumor Suppressor Proteins | 2015 |
[The primary cancer of fallopian tube--a clinical case].
Topics: Aged; Antineoplastic Agents; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Platinum; Taxoids | 2015 |
The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Topics: Accidental Falls; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compounds; Chi-Square Distribution; Female; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Ovarian Neoplasms; Peripheral Nervous System Diseases; Platinum; Prospective Studies; Severity of Illness Index; Taxoids | 2016 |
Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Bridged-Ring Compounds; CD8-Positive T-Lymphocytes; Female; Humans; Immunotherapy; Lymphocytes, Tumor-Infiltrating; Middle Aged; Neoadjuvant Therapy; Ovarian Neoplasms; Platinum; Prognosis; T-Lymphocytes; Taxoids; Tumor Microenvironment | 2017 |
Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Platinum; Postoperative Care; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Uterine Cervical Neoplasms; Young Adult | 2018 |
Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor.
Topics: Animals; Antineoplastic Agents; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Disease Models, Animal; Disease Progression; Epoxide Hydrolases; Female; Inflammation; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, SCID; Ovarian Neoplasms; Platinum; Signal Transduction; Taxoids | 2019 |
Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Topics: Aged; Antineoplastic Agents; Bridged-Ring Compounds; Cancer Survivors; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasms; Pain; Patient Reported Outcome Measures; Peripheral Nervous System Diseases; Platinum; Self Report; Surveys and Questionnaires; Taxoids | 2019 |
Novel Roles for Platinum and Taxane Agent Skin Testing in Risk Stratification of Chemotherapy Hypersensitivity.
Topics: Bridged-Ring Compounds; Humans; Hypersensitivity; Platinum; Risk Assessment; Salts; Taxoids | 2020 |
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cisplatin; Docetaxel; Humans; Male; Mice; Platinum; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-bcl-2; Taxoids | 2021 |
Taxane-based versus platinum-based chemotherapy in early recurrent gastric cancer after radical surgery with S-1 adjuvant chemotherapy: A multi-institutional retrospective analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Stomach Neoplasms; Taxoids | 2022 |
Re: Vicenç Ruiz de Porras, Xieng C. Wang, Luis Palomero, et al. Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment. Eur Urol 2021;79:722-33.
Topics: Bridged-Ring Compounds; Humans; Male; Platinum; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids | 2021 |
The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?
Topics: Bridged-Ring Compounds; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ovarian Neoplasms; Platinum; Receptors, Estrogen; Taxoids | 2022 |
Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis?
Topics: Desensitization, Immunologic; Drug Hypersensitivity; Humans; Platinum; Reproducibility of Results; Salts; Skin Tests; Taxoids | 2022 |
Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4-6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo.
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Humans; Kosovo; Peripheral Nervous System Diseases; Platinum; Platinum Compounds; Prospective Studies; Taxoids | 2022 |